{"transactions":[{"id":2771109,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":138934,"kind":"person","name":"Parkinson Paul","position":1,"cik":"0001826133","reported_name":"Parkinson Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Innovation"}}],"security":"Common Stock","published_at":"2021-03-26T20:37:37.000Z","date":"2021-03-24","kind":"grant","acquired":true,"shares":10661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":87407,"source":{"system":"sec-edgar","filing":"0001826133-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000182613321000004/edgardoc.xml","form_type":"4"}},{"id":2911364,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":138934,"kind":"person","name":"Parkinson Paul","position":1,"cik":"0001826133","reported_name":"Parkinson Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Innovation"}}],"security":"Common Stock","published_at":"2021-01-11T21:40:13.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":11824,"price":25,"value":295600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":76746,"source":{"system":"sec-edgar","filing":"0001826133-21-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000182613321000002/edgardoc.xml","form_type":"4"}},{"id":2996845,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":138934,"kind":"person","name":"Parkinson Paul","position":1,"cik":"0001826133","reported_name":"Parkinson Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Innovation"}}],"security":"Common Stock","published_at":"2020-11-03T02:22:06.000Z","date":"2020-10-31","kind":"disposition_to_issuer","acquired":false,"shares":2218,"price":12.43,"value":27569.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":88570,"source":{"system":"sec-edgar","filing":"0001826133-20-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000182613320000009/edgardoc.xml","form_type":"4"}},{"id":3008753,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":138934,"kind":"person","name":"Parkinson Paul","position":1,"cik":"0001826133","reported_name":"Parkinson Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Innovation"}}],"security":"Common Stock","published_at":"2020-10-13T12:19:33.000Z","date":"2020-10-08","kind":"grant","acquired":true,"shares":21730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024."}],"balance_after":90788,"source":{"system":"sec-edgar","filing":"0001826133-20-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000182613320000007/edgardoc.xml","form_type":"4"}},{"id":3021923,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":138934,"kind":"person","name":"Parkinson Paul","position":1,"cik":"0001826133","reported_name":"Parkinson Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Innovation"}}],"security":"Common Stock","published_at":"2020-09-28T17:10:16.000Z","date":"2020-09-26","kind":"disposition_to_issuer","acquired":false,"shares":3327,"price":12.44,"value":41387.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":69058,"source":{"system":"sec-edgar","filing":"0001826133-20-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000182613320000005/edgardoc.xml","form_type":"4"}},{"id":3021922,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":138934,"kind":"person","name":"Parkinson Paul","position":1,"cik":"0001826133","reported_name":"Parkinson Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Innovation"}}],"security":"Common Stock","published_at":"2020-09-28T17:10:16.000Z","date":"2020-09-25","kind":"disposition_to_issuer","acquired":false,"shares":2218,"price":12.44,"value":27591.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":72385,"source":{"system":"sec-edgar","filing":"0001826133-20-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000182613320000005/edgardoc.xml","form_type":"4"}},{"id":3021921,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":138934,"kind":"person","name":"Parkinson Paul","position":1,"cik":"0001826133","reported_name":"Parkinson Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Innovation"}}],"security":"Common Stock","published_at":"2020-09-28T17:10:16.000Z","date":"2020-09-25","kind":"disposition_to_issuer","acquired":false,"shares":2218,"price":12.44,"value":27591.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":74603,"source":{"system":"sec-edgar","filing":"0001826133-20-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000182613320000005/edgardoc.xml","form_type":"4"}}]}